Form 4: Archimedes Tech SPAC Partners II Co. Director Acquires Shares and Warrants

Sentiment:

SEC Form 4


Long Long, Chief Executive Officer and Director of Archimedes Tech SPAC Partners II Co., reports acquisition of ordinary shares and warrants through the Issuer's sponsor.

Summary

  • On February 12, 2025, Long Long, the CEO and a Director of Archimedes Tech SPAC Partners II Co., reported acquiring 530,000 ordinary shares and 265,000 warrants.
  • These securities were obtained through the purchase of private units by Archimedes Tech SPAC Sponsors II LLC, the Issuer's sponsor, at $10.00 per unit, totaling $5,300,000.
  • Each private unit consists of one ordinary share and one-half of one warrant.
  • Each whole warrant entitles the holder to purchase one ordinary share for $11.50, subject to adjustment.
  • Long Long, as the managing member of the sponsor, has voting and dispositive power over these securities but disclaims beneficial ownership except to the extent of his pecuniary interest.
  • The warrants become exercisable 12 months after the IPO or 30 days after the initial business combination, expiring five years after the business combination or earlier upon redemption or liquidation.

Sentiment

Score: 6

Explanation: Neutral sentiment. The filing reports a standard transaction for a SPAC insider. The acquisition of shares and warrants could be seen as a positive signal, but the disclaimer of beneficial ownership introduces some ambiguity.

Positives

  • The acquisition of shares and warrants by a key insider like the CEO can be seen as a positive signal, indicating confidence in the company's future prospects.

Risks

  • Long Long disclaims beneficial ownership of the securities held by the sponsor, except to the extent of his pecuniary interest therein, which could be interpreted in various ways by investors.
  • The warrants' exercisability is contingent on future events (12 months post-IPO or 30 days after business combination), introducing uncertainty.

Future Outlook

The document does not contain explicit forward-looking statements beyond the terms of the warrants' exercisability and expiration.

Management Comments

  • Long Long disclaims any beneficial ownership of the securities held by the sponsor, except to the extent of his pecuniary interest therein.

Industry Context

This filing is typical for SPACs, where sponsors and insiders often acquire securities before or during the initial public offering. The structure of units consisting of shares and warrants is also standard in the SPAC market.

Comparison to Industry Standards

  • The acquisition of private units by the sponsor is a common practice in the SPAC industry, similar to transactions seen in other SPACs like Churchill Capital Corp or Pershing Square Tontine Holdings.
  • The warrant terms (exercise price, expiration) are also fairly standard compared to other SPACs.
  • The disclaimer of beneficial ownership, except for pecuniary interest, is a legal formality often seen in similar filings.

Related Party Transactions

  • The purchase of private units by Archimedes Tech SPAC Sponsors II LLC, of which Long Long is the managing member, constitutes a related party transaction.

Stakeholder Impact

  • The acquisition could positively influence shareholder sentiment, as it signals insider confidence.
  • The transaction has no immediate impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
02/12/2025Date of transaction: Acquisition of ordinary shares and warrants.

Keywords

Archimedes Tech SPAC Partners II Co., Long Long, ordinary shares, warrants, private units, beneficial ownership, insider trading, ATII, sponsor

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.